BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8904250)

  • 1. [Research for basic and clinical aspects of Behcet's disease--recent advance and future--].
    Sakane T; Miura K
    Nihon Rinsho; 1996 Mar; 54(3):870-84. PubMed ID: 8904250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspective on Behçet's disease.
    Sakane T
    Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiopathology of Behçet's disease: immunological aspects.
    Sakane T; Suzuki N; Nagafuchi H
    Yonsei Med J; 1997 Dec; 38(6):350-8. PubMed ID: 9509903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice.
    Takeno M; Kariyone A; Yamashita N; Takiguchi M; Mizushima Y; Kaneoka H; Sakane T
    Arthritis Rheum; 1995 Mar; 38(3):426-33. PubMed ID: 7880197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.
    Pervin K; Childerstone A; Shinnick T; Mizushima Y; van der Zee R; Hasan A; Vaughan R; Lehner T
    J Immunol; 1993 Aug; 151(4):2273-82. PubMed ID: 7688396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of streptococcal hypersensitivity in the pathogenesis of Behçet's Disease.
    Kaneko F; Oyama N; Yanagihori H; Isogai E; Yokota K; Oguma K
    Eur J Dermatol; 2008; 18(5):489-98. PubMed ID: 18693149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet's disease.
    Yamashita N
    Int Rev Immunol; 1997; 14(1):11-9. PubMed ID: 9203023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behçet's disease].
    Kitaichi N; Ohno S
    Nihon Rinsho; 2005 May; 63 Suppl 5():376-80. PubMed ID: 15954379
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA B51 antigen associated with neutrophil hyper-reactivity.
    Sensi A; Gavioli R; Spisani S; Balboni A; Melchiorri L; Menicucci A; Palumbo G; Traniello S; Baricordi OR
    Dis Markers; 1991; 9(6):327-31. PubMed ID: 1823311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan.
    Kaneko S; Suzuki N; Yamashita N; Nagafuchi H; Nakajima T; Wakisaka S; Yamamoto S; Sakane T
    Clin Exp Immunol; 1997 May; 108(2):204-12. PubMed ID: 9158087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behçet's disease].
    Hashimoto T
    Nihon Rinsho; 1999 Feb; 57(2):374-7. PubMed ID: 10078008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid.
    Quayle AJ; Wilson KB; Li SG; Kjeldsen-Kragh J; Oftung F; Shinnick T; Sioud M; Førre O; Capra JD; Natvig JB
    Eur J Immunol; 1992 May; 22(5):1315-22. PubMed ID: 1577070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behçet's disease: an update on the pathogenesis.
    Gül A
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S6-12. PubMed ID: 11760403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP 60 expression in mucocutaneous lesions of Behçet's disease.
    Ergun T; Ince U; Ekşioğlu-Demiralp E; Direskeneli H; Gürbüz O; Gürses L; Aker F; Akoğlu T
    J Am Acad Dermatol; 2001 Dec; 45(6):904-9. PubMed ID: 11712037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited restriction in the TCR-alpha beta V region usage of antigen-specific clones. Recognition of myelin basic protein (amino acids 84-102) and Mycobacterium bovis 65-kDa heat shock protein (amino acids 3-13) by T cell clones established from peripheral blood mononuclear cells of monozygotic twins and HLA-identical individuals.
    Hawes GE; Struyk L; Godthelp BC; van den Elsen PJ
    J Immunol; 1995 Jan; 154(2):555-66. PubMed ID: 7529279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.
    Soto-Vega E; García-Muñoz R; Richaud-Patin Y; Zúñiga-Ramos J; Crispín JC; Díaz-Jouanen E; Flores-Suárez LF; Llorente L; Granados J
    Immunol Lett; 2004 May; 93(2-3):211-5. PubMed ID: 15158619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic gene responsible for the predisposition of Behçet's disease.
    Mizuki N; Inoko H; Ohno S
    Int Rev Immunol; 1997; 14(1):33-48. PubMed ID: 9203025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.
    Suzuki Y; Hoshi K; Matsuda T; Mizushima Y
    J Rheumatol; 1992 Apr; 19(4):588-92. PubMed ID: 1534375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behçet's disease].
    Sakane T; Nishikawa M
    Nihon Rinsho; 1993 Jan; 51 Suppl():596-610. PubMed ID: 8459593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.